Public Health News Roundup: August 26
Preschoolers’ Stuttering Does Not Hurt Social, Emotional Development
Stuttering is a common issue and does not negatively impact the social and emotional development of preschoolers, according to a new study in the journal Pediatrics. Sheena Reilly, associate director of clinical and public health research at Murdoch Children’s Research Institute in Australia and the study's lead author, called the study’s conclusion that stuttering or stammering did not serve to make kids more withdrawn a “very positive finding” and said that parents "can be reassured that developmental stuttering is not associated with a range of poorer outcomes in the preschool years." Researchers found that the rate of kids stuttering by age four was 11 percent and the recovery rate from stuttering after 12 months was 6.3 percent. The former was higher than previous studies have indicated and the latter was lower than the researchers expected; Reilly said further research into recovery is needed. The study also found that children who stutter had higher verbal and non-verbal scores. Read more on pediatrics.
NIH: Parents Fully Informed on Blood Transfusion Trial on Premature Infants
The U.S. National Institutes of Health (NIH) late last week responded to an advocacy group’s call for the end of a government study of blood transfusion levels in premature infants with firm insistence that parents are given complete and accurate information about the risks. The organization, Public Citizen, contends that the study exposes the infants to risks without giving parents full information and should be stopped. Under the study, half of the children will receive transfusions at a high hemoglobin level and half at a low level; according to Public Citizen, a restrictive approach risks serious complications such as neurological injury. As reported by Reuters, "The NIH said it is committed to ensuring that prospective research participants — and the people who speak for and love them — are given clear complete, and accurate information about the risks and benefits of participating in research." Public Citizen earlier called for a closer look at a previous NIH study on the effectiveness of different levels of oxygen in the treatment of premature infants. Read more on research.
Report: Most Medications Safe to Take While Breastfeeding
Most medications taken by breastfeeding moms will have no harmful impact on nursing infants, according to a new report from the American Academy of Pediatrics in consultation with the U.S. Food and Drug Administration (FDA). The study appears in the journal Pediatrics. "Because we know that breast-feeding has both developmental and health benefits for the mom and the baby, we are encouraging research in this area so physicians can make informed decisions about how best to treat their patients," said study author Hari Cheryl Sachs, MD, a pediatrician and leader of the pediatric and maternal health team within the FDA's Center for Drug Evaluation and Research. FDA is proposing new regulations that would replace “Nursing Mothers” sections on drug labels with a “Lactation” section that would provide more detailed information about potential effects on a nursing infant. Most drugs currently carry a blank legal statement warning against any use by breastfeeding mothers. "The general takeaway message—that most drugs are compatible with breast-feeding, that mothers don't have to wean to take drugs and that the labels should accurately reflect the science—is really great news and progress for breast-feeding mothers," said Diana West, a lactation consultant and spokesperson for La Leche League International. Read more on maternal and infant health.